Android app Apple app link

MapLight Therapeutics Inc. (MPLT)

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$18.38
Day's range
$20

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/31/2026 Needham Ami Fadia $43.00 $12.60   241.27%
08/14/2026 Canaccord Genuity Sumant Kulkarni $21.00 $11.63   80.57%
07/28/2026 Craig-Hallum Adam Vogel $25.00 $10.21   144.86%
07/28/2026 Canaccord Genuity Sumant Kulkami $24.00 $9.91   142.3%
07/28/2026 H.C. Wainwright Raghuram Selvaraju $26.00 $9.91   162.49%
07/27/2026 Wolfe Research Rudy Li $30.00 $9.91   202.88%
07/24/2026 Canaccord Genuity Sumant Kulkarni $43.00 $35.23   22.06%
06/01/2026 Stifel Nicolaus Paul Matteis $36.00 $29.76   20.97%
05/26/2026 UBS Ashwani Verma $48.00 $29.46   62.93%
05/21/2026 Craig-Hallum Adam Vogel $43.00 $27.81   54.62%
05/04/2026 H.C. Wainwright Raghuram Selvaraju $45.00 $30.70   46.58%
11/21/2025 Leerink Partners Marc Goodman $30.00 $13.29   125.73%
11/21/2025 Jefferies Andrew Tsai $32.00 $13.29   140.78%

MapLight Therapeutics Inc. FAQ's

MapLight Therapeutics Inc. has been rated by research analysts at Needham, Canaccord Genuity, Raymond James, UBS, Craig-Hallum, Morgan Stanley in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.